(MGNX) MacroGenics - Performance -65.2% in 12m
MGNX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-91.38%
#189 in Peer-Group
Rel. Strength
5.55%
#7249 in Stock-Universe
Total Return 12m
-65.24%
#154 in Peer-Group
Total Return 5y
-94.94%
#148 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 5.55 USD |
| 52 Week Low | 1.06 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 73.74 |
| Buy/Sell Signal +-5 | 2.16 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: MGNX (-65.2%) vs XBI (-7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.23% | 73% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.1% | -6.38% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
3.91% | -0.97% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.34% | 27.6% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.69% | -7.17% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
18.3% | 43% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.03% | 58.7% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.2% | 28.7% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: MGNX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for MGNX
| Total Return (including Dividends) | MGNX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -2.67% | 3.36% | 5.25% |
| 3 Months | 37.74% | 15.73% | 24.13% |
| 12 Months | -65.24% | -7.02% | 14.15% |
| 5 Years | -94.94% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | MGNX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -72.4% | 4.4% | 81% |
| 3 Months | 4.3% | 78.8% | 96.9% |
| 12 Months | -89.8% | -85.8% | 44.9% |
| 5 Years | -80.4% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th45.00 | -5.83% | -7.52% |
| 3 Month | %th69.50 | 19.01% | 10.96% |
| 12 Month | %th23.50 | -62.61% | -69.55% |
| 5 Years | %th26.50 | -93.33% | -97.61% |
FAQs
Does MacroGenics (MGNX) outperform the market?
No,
over the last 12 months MGNX made -65.24%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.02%.
Over the last 3 months MGNX made 37.74%, while XBI made 15.73%.
Performance Comparison MGNX vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
MGNX vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 21% | -7.9% | -63.8% | -79% |
| US NASDAQ 100 | QQQ | 21.2% | -8% | -64.5% | -78% |
| German DAX 40 | DAX | 23.1% | -1.3% | -76% | -94% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 21.2% | -5.9% | -67.3% | -85% |
| Hongkong Hang Seng | HSI | 21.4% | -8.7% | -83.3% | -104% |
| India NIFTY 50 | INDA | 22.8% | -6.1% | -64.2% | -64% |
| Brasil Bovespa | EWZ | 18.5% | -11.5% | -88.9% | -75% |
MGNX vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 22.4% | -8.6% | -68% | -90% |
| Consumer Discretionary | XLY | 21.5% | -5.8% | -56.2% | -83% |
| Consumer Staples | XLP | 20.7% | -3.3% | -65.5% | -74% |
| Energy | XLE | 20.7% | -9.7% | -59.7% | -65% |
| Financial | XLF | 20.3% | -7.8% | -68.8% | -95% |
| Health Care | XLV | 21.5% | -4.8% | -56.5% | -61% |
| Industrial | XLI | 20.9% | -6.9% | -71.7% | -90% |
| Materials | XLB | 18.7% | -7% | -68.4% | -71% |
| Real Estate | XLRE | 21% | -3.7% | -63.6% | -78% |
| Technology | XLK | 20.2% | -11.4% | -66.2% | -76% |
| Utilities | XLU | 22.1% | -4.5% | -67.1% | -88% |
| Aerospace & Defense | XAR | 23.1% | -9.7% | -82.4% | -115% |
| Biotech | XBI | 20% | -6% | -50.6% | -58% |
| Homebuilder | XHB | 18.5% | -9.7% | -56.7% | -71% |
| Retail | XRT | 18.5% | -7.7% | -59.5% | -77% |
MGNX vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 20.1% | -11.1% | -55.4% | -58% |
| Natural Gas | UNG | 30.5% | 7.2% | -47% | -63% |
| Gold | GLD | 20.7% | -1.5% | -84.5% | -104% |
| Silver | SLV | 20% | -9.6% | -81.2% | -83% |
| Copper | CPER | 21.9% | -7.3% | -80.9% | -76% |
MGNX vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 22.8% | -3.7% | -60.4% | -63% |
| iShares High Yield Corp. Bond | HYG | 22.2% | -4.3% | -62.7% | -75% |